255.37
First Trust Nyse Arca Biotechnology Index Fund stock is traded at $255.37, with a volume of 39,878.
It is up +2.45% in the last 24 hours and up +18.85% over the past month.
See More
Previous Close:
$249.26
Open:
$251.51
24h Volume:
39,878
Relative Volume:
0.67
Market Cap:
$3.19B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+5.45%
1M Performance:
+18.85%
6M Performance:
+22.94%
1Y Performance:
+55.95%
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Company Profile
Name
First Trust Nyse Arca Biotechnology Index Fund
Sector
Industry
Phone
-
Address
-
Compare FBT vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
FBT
First Trust Nyse Arca Biotechnology Index Fund
|
255.37 | 3.19B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Latest News
Price-Driven Insight from (FBT) for Rule-Based Strategy - Stock Traders Daily
First Trust NYSE Arca Biotechnology Index Fund (FBT) Stock Price Quote Today & Current Price Chart - Capital.com
Why Is Natera Stock Gaining Tuesday? - Sahm
Genmab A/S (GMAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waters Corp (WAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exact Sciences Corp (EXAS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mettler-Toledo International Inc (MTD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioMarin Pharmaceutical Inc (BMRN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ACADIA Pharmaceuticals Inc (ACAD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regeneron Pharmaceuticals Inc (REGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Krystal Biotech Inc (KRYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Repligen Corp (RGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alkermes Plc (ALKS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neurocrine Biosciences Inc (NBIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
argenx SE (ARGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biogen Inc (BIIB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incyte Corp (INCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exelixis Inc (EXEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beigene Ltd (ONC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Halozyme Therapeutics Inc (HALO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(FBT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - AOL.com
Investors Evaluate FBT and XPH for Strategic Healthcare Exposure - asatunews.co.id
State Street vs First Trust: Comparing Two Healthcare ETFs - IndexBox
SPDR S&P Pharmaceuticals and First Trust NYSE Arca Biotech ETFs Offer Distinct Healthcare Paths - sekbernews.id
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - The Motley Fool
(FBT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
(FBT) Risk Channels and Responsive Allocation - Stock Traders Daily
(FBT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Should you invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - MSN
Is First Trust NYSE Arca Biotechnology ETF (FBT) a strong ETF right now? - MSN
EDGAR Filing Documents for 0001445546-23-002834 - SEC.gov
EDGAR Filing Documents for 0001445546-18-002120 - SEC.gov
EDGAR Filing Documents for 0001445546-20-002174 - SEC.gov
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
Liquidity Mapping Around (FBT) Price Events - Stock Traders Daily
Moderna's Legal Hit Steals Spotlight From Strong Sales - Sahm
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Why (FBT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
First Trust NYSE Arca Biotechnology Index Fund (FBT) - Minichart
Mix-And-Match Sector Fund Boosts Performance - Stock Investor
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Financials Data
There is no financial data for First Trust Nyse Arca Biotechnology Index Fund (FBT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):